References
- Arribas, F., Auricchio, A., Boriani, G., Brugada, J.,Deharo, J. C, Hindriks, G., Kuck, K. H., Merino, J. L., Vardas, P., Wolpert, C., Zeppenfeld, K. (2014). Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA). Europace, 16 (suppl 1), i1–i78.
- Auricchio, A., Prinzen, F. (2011). Non-responders to cardiac resynchronization therapy. The magnitude of the problem and the issues. Circulation, 75, 521–527.
- Barsheshet, A., Goldenberg, I., Moss, A. J., Eldar, M., Huang, D. T., McNitt, S., Klein, H. U., Hall, W. J., Brown, M. W., Goldberger, J. J., Goldstein, R. E., Schuger, C., Zareba, W., Daubert, J. P. (2011). Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur. Heart J., 32, 1622–1630.
- Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G, Breithardt, O. A., Cleland, J., Deharo, J. C, Delgado, V., Elliott, P. M., Gorenek, B., Israel, C. W., Leclercq, C., Linde, C., Mont, L., Padeletti, L., Sutton, R., Vardas, P. E. (2013). 2013 ESC Guidelines on cardiac pacing and cardiacresynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur. Heart J., 34, 2281–2329.
- Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., DeVries, D. W., Feldman, A. M. (2004). Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New Engl. J. Med., 350, 2140–2150.
- Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl. J. Med., 352, 1539–1549.
- Daubert, C., Gold, M. R., Abraham, W. T., Ghio, S., Hassager, C., Goode, G., Szili-Török, T., Linde, C. (2009). Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: Insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J. Amer. Coll. Cardiol., 54, 1837–1846.
- Daubert, J. C., Saxon, L., Adamson, P.B., Auricchio, A., Berger, R. D., Beshai, J. F., Breithard, O., Brignole, M., Cleland, J., DeLurgio, D. B., Dickstein, K., Exner, D. V., Gold, M., Grimm, R. A., Hayes, D. L., Israel, C., Leclercq, C., Linde, C., Lindenfeld, J., Merkely, B., Mont, L., Murgatroyd, F., Prinzen, F., Saba, S. F., Shinbane, J. S., Singh, J., Tang, A. S., Vardas, P. E., Wilkoff, B. L., Zamorano, J. L,, Anand, I., Blomström-Lundqvist, C., Boehmer, J. P., Calkins, H., Cazeau, S., Delgado, V., Estes, N. A., Haines, D., Kusumoto, F., Leyva, P., Ruschitzka, F., Stevenson, L. W., Torp-Pedersen, C. T. (2012). 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: Implant and follow-up recommendations and management. Europace, 14 (9), 1236–1286.
- Dickstein, K, Cohen-Solal, A, Filippatos, G, McMurray, J.J, Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K. (2008). ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J., 29 (19), 2388–2442.
- Goldenberg, I., Kutyifa, V., Klein, H. U., Cannom, D. S., et al. (2014). Survival with cardiac-resynchronization therapy in mild heart failure. New Engl. J. Med., 370, 1694–1701.
- Leong, D. P., Höke, U., Delgado, V., Auger, A., Thijssen, J. van Erven, L., Bax, J. J., Schalij, M. J., Marsan, N. A. (2012). Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch block. Eur. Heart J., 33 (15), 1934–1941.
- McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., et al. (2012). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J., doi:10.1093/eurheartj/ehs104.10.1093/eurheartj/ehs104
- Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. 3rd, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl. J. Med., 361, 1329–1338.
- Sipahi, I., Carrigan, T. P., Rowland, D.Y., Stambler, B. S., Fang, J. C. (2011). Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials. Arch. Intern. Med., 171, 1454–1462.
- Singh, J. P., Klein, H. U., Huang, D. T., Reek, S., Kuniss, M., Quesada, A., Barsheshet, A., Cannom, D., Goldenberg, I., McNitt, S., Daubert, J. P., Zareba, W., Moss, A. J. (2011). Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation, 123, 1159–1166.
- Stavrakis, S., Lazzara, R., Thadani, U. (2012). The benefit of cardiac resynchronization therapy and QRS duration: A meta-analysis. J. Cardiovasc. Electrophysiol., 23, 163–168.
- Vardas, P., Auricchio, A., Merino, J. L. (2012). The EHRA White Book 2011. The Current Status of Cardiac Electrophysiology in ESC Member Countries. Available from: https://www.escardio.org/static_file/Escardio/Subspecialty/EHRA/Publications/Documents/EHRA%20White%20Book%202011.pdf (accessed 15.11.2018).
- Yi-Zhou, X., Friedman, P.A., Webster, T., Brooke, K., Hodge, D. O., Wiste, H. J., Hua, W., Zhang, S., Hayes, D. L., Cha, Y. M. (2012). Cardiac resynchronization therapy: Do women benefit more than men? J. Cardiovasc. Electrophysiol., 23 (2), 172–178.
- Yu, C.M., Bleeker, G. B., Fung, J. W., Schalij, M. J., Zhang, Q., Van der Wall, E. E., Chan, Y. S., Kong, S. L., Bax, J. J. (2005). Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation, 112, 1580–1586.
- Zabarovskaja, S., Gadler, F., Braunschweig, F., Ståhlberg, M., Hörnsten, J., Linde, C., Lund, L. H. (2012). Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace, 14 (8), 1148–1155.
- Zareba, W., Klein, H., Cygankiewicz, I., Hall, W. J., McNitt, S., Brown, M., Cannom, D., Daubert, J. P., Eldar, M., Gold, M. R., Goldberger, J. J., Goldenberg, I., Lichstein, E., Pitschner, H., Rashtian, M., Solomon, S., Viskin, S., Wang, P., Moss, A. J. (2011) Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 123, 1061–1072.